NSE filing, NSE: APOLLOHOSP. Summary written from the filing by ALFA Finder's alert engine.
Apollo Hospitals Enterprise Ltd: key numbers
- Share price
- ₹8,137.00
- Market cap
- ₹1,16,998 Cr
- Revenue (annual)
- ₹25,228 Cr
- Net profit (annual)
- ₹1,942 Cr
- P/E (TTM)
- 56.0×Sector 52.0×
- Promoter holding
- 28.02%+0.00% QoQ
- FII holding
- 43.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Apollo Hospitals Enterprise Ltd
All →Apollo Hospitals Enterprise Board Meeting Date
Apollo Hospitals will hold a board meeting on 04 Nov 2026 to consider Q1 FY27 financial results. No financial figures are disclosed in this advance intimation.
Apollo Hospitals Enterprise Other Announcement
Apollo Hospitals Enterprise Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.
Apollo Hospitals Enterprise Share Pledge
Apollo Hospitals Enterprise promoter K Vishweshwar Reddy created a pledge on 200,000 equity shares worth ₹177.78 Crore. This transaction reflects a change in promoter encumbrance status.
- Value
- ₹177.8 Cr
Apollo Hospitals Enterprise Annual General Meeting
Apollo Hospitals Enterprise Limited conducted its 45th Annual General Meeting on August 25, 2026. The proceedings covered routine items and resolutions, including NCD issuance approval.
Apollo Hospitals Enterprise Earnings Call Transcript: Key Takeaways
Apollo started FY27 with 21% revenue growth, driven by a 22% surge in Healthcare Services and improved digital health economics.
- Call
- Guides 20% growth
Apollo Hospitals Enterprise Investor Presentation: Key Takeaways
Apollo Hospitals reported strong Q1FY27 consolidated revenue growth of 21% YoY to ₹70,435 mio, driven by robust healthcare services and diagnostics performance alongside narrowing digital cash losses.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.